Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer

Neuroinflammation Clinical Trial

Official title:
A Non-randomized, Open-label, Exploratory Study With A Non-pharmacologically Active Dose To Evaluate The Binding Kinetics Of A Novel Monoacylglicerol Lipase Positron Emission Tomography Radiotracer [11C]PF-06809247 In Healthy Male Subjects

Status Completed

Clinical Trial Summary

This is a study measuring the binding kinetics and test-retest characteristics of a subpharmacological dose of [11C]PF-06809247 Monoacylglycerol lipase (MAGL) Positron Emission Tomography (PET) tracer in healthy adult subjects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Neuroinflammation

Clinical Trial Details

NCT number	NCT03100136
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	November 16, 2016
Completion date	March 10, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06432023` - Imaging - Clinical Evaluation of Altered Nervous System Drainage
Not yet recruiting	`NCT05129514` - Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery	N/A
Recruiting	`NCT04318626` - The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment	Phase 2
Enrolling by invitation	`NCT05350774` - Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2	Phase 2
Completed	`NCT03058328` - The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.
Withdrawn	`NCT04423471` - Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
Recruiting	`NCT04814355` - The Effect of Celecoxib on Neuroinflammation in MDD	Phase 4
Recruiting	`NCT06391866` - Neuroinflammation/Oxidative Stress/Cardiac Surgery